Lukasz Skalniak

22PUBLICATIONS
55CO-AUTHORS
Proteins and peptidesMolecular targetsMolecular medicineBiomolecular modelling and designBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Feb 23, 2026
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy.

Francesco Merlino, Valentina Pagliara, Vincenzo Maria D'Amore

|Jul 16, 2025
Characterization of Clinically Evaluated Small-Molecule Inhibitors of PD-L1 for Immunotherapy.

Alicja Slota, Katarzyna Golebiowska-Mendroch, Justyna Kocik-Krol

|May 07, 2025
Correction: Musielak et al. CA-170 - A Potent Small-Molecule PD-L1 Inhibitor or Not? Molecules 2019, 24, 2804.

Bogdan Musielak, Justyna Kocik, Lukasz Skalniak

|Jun 21, 2024
An updated patent review on PD-1/PD-L1 antagonists (2022-present).

Wiktor Uzar, Beata Kaminska, Hubert Rybka

|Jun 19, 2024
C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein-Protein Interaction.

Joanna Klimek, Oskar Kruc, Joanna Ceklarz

|Jan 17, 2024
Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for m-Terphenyl Derivatives.

Ewa Surmiak, Julia Ząber, Jacek Plewka

Pageof 4

Frequent Collaborators

9 joint publications

Justyna Kocik-Krol

9 joint publications

Bogdan Musielak

8 joint publications

Tad A Holak

8 joint publications

Ewa Surmiak